Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir

Overton, T.Aberg, J. A.Gupta, S.Ryan, R.Baugh, B.De La Rosa, G.2025-03-062025-03-062010-11-08Overton T, Aberg JA, Gupta S, Ryan R, Baugh B, De La Rosa G. Metabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavir. J Int AIDS Soc. 2010;13(Suppl 4):P74. Published 2010 Nov 8. doi:10.1186/1758-2652-13-S4-P74https://hdl.handle.net/1805/46240en-USAttribution 4.0 InternationalProtease inhibitorsMetabolic complicationsCardiovascular riskHIV infectionDarunavir/ritonavir (DRV/r) based therapyAtazanavir/ritonavir (ATV/r) based therapyMetabolic: week 48 comparison of metabolic parameters and biomarkers in subjects receiving darunavir/ritonavir or atazanavir/ritonavirArticle